Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Astrazeneca Pharma India LtdIndustry : Pharmaceuticals - Multinational
BSE Code:506820NSE Symbol: ASTRAZENP/E(TTM):89.62
ISIN Demat:INE203A01020Div & Yield %:0.39EPS(TTM):92.47
Book Value(Rs):319.6Market Cap ( Cr.):20718.38Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 1716.291295.531002.97805.60813.56831.81
Excise Duty0.000.000.000.000.000.00
Net Sales1716.291295.531002.97805.60813.56831.81
Other Income 40.6351.2326.1014.7612.8412.99
Stock Adjustments 332.9433.7748.86-14.47-2.9539.21
Total Income2089.861380.531077.93805.89823.45884.01
EXPENDITURE :      
Raw Materials 1295.95628.33408.84297.49292.00344.44
Power & Fuel Cost5.304.875.548.107.377.72
Employee Cost 257.44241.45259.10230.21219.54216.70
Other Manufacturing Expenses 18.4514.3813.798.059.119.04
Selling and Administration Expenses 204.24234.33185.72145.09129.72157.71
Miscellaneous Expenses 110.6721.4953.9516.0117.4014.71
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1892.051144.85926.94704.95675.14750.32
Operating Profit197.81235.68150.99100.94148.31133.69
Interest 1.461.200.630.951.091.14
Gross Profit196.35234.48150.3699.99147.22132.55
Depreciation39.9914.9416.2616.9520.1318.58
Profit Before Tax156.36219.54134.1083.04127.09113.97
Tax60.5458.9338.3022.6334.8331.51
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-19.92-0.90-3.49-1.19-1.0410.25
Reported Net Profit115.74161.5199.2961.6093.3072.21
Extraordinary Items -59.3912.45-26.962.051.580.18
Adjusted Net Profit175.13149.06126.2559.5591.7272.03
Adjst. below Net Profit -1.171.00-2.61-1.743.43-5.43
P & L Balance brought forward578.15455.64378.96324.10232.37168.09
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 60.0040.0020.005.005.002.50
P & L Balance carried down632.72578.15455.64378.96324.10232.37
Dividend0.000.000.005.005.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1600.001200.00800.00500.00100.0050.00
Earnings Per Share-Unit Curr46.3064.6039.7224.6437.3228.88
Earnings Per Share(Adj)-Unit Curr46.3064.6039.7224.6437.3228.88
Book Value-Unit Curr308.14284.77235.48204.56182.47145.78